NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
3.490
+0.050 (1.45%)
At close: Jul 28, 2026, 4:00 PM EDT
3.460
-0.030 (-0.86%)
Pre-market: Jul 29, 2026, 7:33 AM EDT
NeOnc Technologies Holdings Employees
NeOnc Technologies Holdings had 5 employees as of December 31, 2025. The number of employees decreased by 3 or -37.50% compared to the previous year.
Employees
5
Change
-3
Growth
-37.50%
Revenue / Employee
n/a
Profits / Employee
-$7,728,025
Market Cap
90.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 5 | -3 | -37.50% |
| Dec 31, 2023 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| Adicet Bio | 102 |
| Pelthos Therapeutics | 92 |
| Verrica Pharmaceuticals | 76 |
| Biomea Fusion | 40 |
| Oncolytics Biotech | 29 |
| Rallybio | 9 |
| Coya Therapeutics | 8 |
NTHI News
- 2 days ago - NeOnc Technologies Appoints Strategy and Finance Executive Nasim Shomali to its Board of Directors - GlobeNewsWire
- 14 days ago - NeOnc Receives FDA Written Feedback on NEO212 CMC Development and Capsule-to-Tablet Transition - GlobeNewsWire
- 27 days ago - Wall Street is Watching These Biotechs - GlobeNewsWire
- 5 weeks ago - NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum - GlobeNewsWire
- 5 weeks ago - NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone - GlobeNewsWire
- 5 weeks ago - NeOnc Technologies Holdings Proxy statement: Proxy filing - Filings
- 5 weeks ago - NeOnc Technologies Holdings Proxy statement: Proxy filing - Filings
- 5 weeks ago - WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy - Newsfile Corp